Igc Pharma, Inc. (IGC) Stock Price & Analysis
Igc Pharma, Inc. (IGC) fell 0.17% to USD 0.3 as of September 8, 2026 at 09:05 UTC, according to Nexqual real-time market data.
IGC last closed at USD 0.3; the session ranged USD 0.3–0.3 on volume of 368,914 shares. Market capitalization is —, with a 52-week range of USD 0.24–0.45 (ASE). Source: Nexqual, September 8, 2026 at 09:05 UTC.
Key Statistics (as of September 8, 2026 at 09:05 UTC)
| Price | USD 0.3 |
|---|---|
| Change | ▼ 0.17% (down) |
| Previous Close | USD 0.3 |
| Open | USD 0.3 |
| Day Range | USD 0.3 – 0.3 |
| 52-Week Range | USD 0.24 – 0.45 |
| Volume | 368,914 shares |
| Market Cap | — |
| Exchange | ASE |
Technical Analysis (IGC)
Nexqual's technical model rates IGC "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 09:05 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 54.09 (neutral) |
| vs SMA50 | Above (USD 0.28) |
| MACD | 0.01 (positive) |
From Igc Pharma, Inc.'s Latest SEC 10-K Filing (filed 2025-06-27)
Key Strengths & Strategy (as disclosed to the SEC)
- Our IP strategy is centered on securing exclusive rights to proprietary technologies, inventions, and product candidates through the development, acquisition, and licensing of patents and related protections both in the United States and internationally.   We actively seek to protect our innovations by filing patent applications that cover novel methods, compositions, and uses associated with our investigational drug candidates, formulations, and related technologies.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OGEN | Oragenics Inc. | USD 0.51 | ▲ 0% |
| VTVT | vTv Therapeutics Inc. | USD 33.35 | ▼ 0.15% |
| XXII | 22nd Century Group, Inc | USD 2.45 | ▲ 4.7% |
| CVSI | CV Sciences, Inc. | USD 0.02 | ▲ 0% |
| PRPO | Precipio, Inc. | USD 27.4 | ▼ 0.36% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:05 UTC. This page is informational and not investment advice.